朗姿股份(002612) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥1,264,518,550.01, a decrease of 6.80% compared to ¥1,356,840,503.00 in the same period last year[2] - Net profit attributable to shareholders was ¥42,253,078.39, down 17.21% from ¥51,037,261.72 year-on-year[2] - The net profit excluding non-recurring gains and losses increased by 10.60% to ¥39,716,427.48 from ¥35,910,433.83 in the previous year[2] - Cash flow from operating activities for the year-to-date was ¥356,334,763.58, a decline of 45.51% compared to ¥653,890,668.14 last year[2] - Total operating revenue for the period reached RMB 4,177,866,888.21, a slight increase of 1.4% compared to RMB 4,118,243,275.40 in the previous period[21] - Net profit for the period was RMB 232,258,584.37, down 5.6% from RMB 246,071,065.66 in the previous period[22] - Operating profit increased to RMB 310,135,872.94, compared to RMB 299,861,637.77 in the previous period, reflecting a growth of 3.8%[22] - The total comprehensive income for the period was RMB 206,184,543.79, down from RMB 223,941,918.08 in the previous period[23] - Basic earnings per share decreased to 0.4729 from 0.4971 in the previous period, reflecting a decline of 4.4%[23] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥8,270,571,244.59, reflecting a decrease of 1.11% from the previous year[4] - The company's total current liabilities increased to RMB 3.07 billion from RMB 2.87 billion, marking an increase of approximately 7%[19] - The company's total liabilities increased to RMB 4,479,993,596.72, up from RMB 4,128,326,339.99, indicating a growth of 8.5%[20] - The company's total equity decreased to RMB 3,790,577,647.87 from RMB 4,234,698,594.25, a decline of 10.5%[20] Cash and Cash Equivalents - The company's cash and cash equivalents increased by 36.97% to ¥601,591,952.95, primarily due to cash flow from operating activities[4] - As of the reporting date, the company’s cash and cash equivalents increased to RMB 601.59 million from RMB 439.23 million at the beginning of the period, representing a growth of approximately 37%[18] - The net increase in cash and cash equivalents was $144,362,648.52, contrasting with a decrease of -$109,961,493.65 in the prior period, demonstrating improved liquidity[25] - The ending balance of cash and cash equivalents stood at $573,020,952.95, up from$329,194,682.19, reflecting a stronger cash position[25] Investments and Acquisitions - The company plans to acquire 100% equity of Zhengzhou Jimei Medical Beauty Hospital, with a total transaction price of 154.92 million RMB[13] - The assessed value of Zhengzhou Jimei's total equity is 155.15 million RMB as of December 31, 2023[13] - The acquisition will be completed in the first quarter of 2024 and will be included in the company's consolidated financial statements[13] - The company approved the cash acquisition of 100% equity in Beijing Lidu and 70% equity in Hunan Yamei, with valuations of RMB 330 million and RMB 360 million respectively as of June 30, 2024[14] - The transfer prices for the equity stakes were set at RMB 264 million for 80% and RMB 66 million for 20% of Beijing Lidu, and RMB 252 million for 70% of Hunan Yamei[14] - The total cash investment for establishing Langxi Ziyan Medical Device Co., Ltd. is RMB 100 million, with contributions of RMB 15 million from the company, RMB 20 million from Wuhu Boheng No. 3, and RMB 65 million from Langxi Aesthetics[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 59,498[7] - The largest shareholder, Shen Dongri, holds 47.82% of the shares, totaling 211,559,098 shares, with 42,340,000 shares pledged[7] - Shen Dongri and Shen Jinhua, who hold 47.82% and 6.76% of the shares respectively, are siblings and have a close relationship[9] - The company has a total of 1.12% of shares held by Hong Kong Central Clearing Limited, totaling 4,953,372 shares[9] - The company has a total of 2.13% of shares held by the third-phase employee stock ownership plan, totaling 9,420,000 shares[7] Other Financial Activities - Investment income decreased by 58.52% to ¥21,730,450.68, mainly due to reduced returns from associated companies[6] - The company reported a significant increase in other income, which rose by 521.92% to ¥6,196,136.54, primarily from the settlement of historical payables[6] - The company has engaged in financing and securities lending activities, with specific details on the shares involved[12] - Cash inflow from investment activities totaled $1,061,299,988.82, a significant increase from$243,540,174.63 in the previous period, indicating strong investment performance[25] - Net cash outflow from investment activities was -$142,536,959.02, an improvement compared to -$381,761,472.97 in the prior period, reflecting better cash management[25] - Cash inflow from financing activities reached $1,297,414,297.36, slightly up from$1,227,073,789.55, showing stable financing operations[25] - Net cash outflow from financing activities was -$63,188,161.91, a notable improvement from -$376,768,292.62 in the previous period, indicating reduced financing costs[25] Audit and Compliance - The company did not undergo an audit for the third quarter report, which may affect investor confidence in the reported figures[26]